Trials / Completed
CompletedNCT05149599
Saccharomyces Cerevisiae for Irritable Bowel Syndrome
Efficacy and Safety of Saccharomyces Cerevisiae for Abdominal Pain and Discomfort in Irritable Bowel Syndrome (IBS) Patients
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Ziauddin University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to see the response of saccharomyces cerevisiae for symptomatic improvement of patients with IBS
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Saccharomyces cerevisiae | Saccharomyces cerevisiae, which is a pro-biotic, was given in capsule form, 500mg twice daily for 1 month |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2021-10-31
- Completion
- 2021-10-31
- First posted
- 2021-12-08
- Last updated
- 2022-12-07
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05149599. Inclusion in this directory is not an endorsement.